7364 related articles for article (PubMed ID: 2043590)
1. Antitumor activity of a novel chimera tumor necrosis factor (TNF-STH) constructed by connecting rTNF-S with thymosin beta 4 against murine syngeneic tumors.
Noguchi K; Inagawa H; Tsuji Y; Morikawa A; Mizuno D; Soma G
J Immunother (1991); 1991 Apr; 10(2):105-11. PubMed ID: 2043590
[TBL] [Abstract][Full Text] [Related]
2. Antitumor effect of systemic administration of novel recombinant tumor necrosis factor (rTNF-S) with less toxicity than conventional rTNF-alpha in vivo.
Gatanaga T; Noguchi K; Tanabe Y; Inagawa H; Soma G; Mizuno D
J Biol Response Mod; 1989 Jun; 8(3):278-86. PubMed ID: 2746298
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human tumor necrosis factor-alpha: evidence of an indirect mode of antitumor activity.
Manda T; Shimomura K; Mukumoto S; Kobayashi K; Mizota T; Hirai O; Matsumoto S; Oku T; Nishigaki F; Mori J
Cancer Res; 1987 Jul; 47(14):3707-11. PubMed ID: 3594435
[TBL] [Abstract][Full Text] [Related]
4. TNF induces endogenous TNF in vivo: the basis of EET therapy as a combination of rTNF together with endogenous TNF.
Inagawa H; Oshima H; Soma G; Mizuno D
J Biol Response Mod; 1988 Dec; 7(6):596-607. PubMed ID: 3216223
[TBL] [Abstract][Full Text] [Related]
5. Antitumor effect of recombinant tumor necrosis factor-alpha against murine sarcomas at visceral sites: tumor size influences the response to therapy.
Mulé JJ; Asher A; McIntosh J; Lafreniere R; Shiloni E; Lefor A; Reichert CM; Rosenberg SA
Cancer Immunol Immunother; 1988; 26(3):202-8. PubMed ID: 3383204
[TBL] [Abstract][Full Text] [Related]
6. The antitumor function of tumor necrosis factor (TNF), I. Therapeutic action of TNF against an established murine sarcoma is indirect, immunologically dependent, and limited by severe toxicity.
Havell EA; Fiers W; North RJ
J Exp Med; 1988 Mar; 167(3):1067-85. PubMed ID: 3351434
[TBL] [Abstract][Full Text] [Related]
7. Anti-tumor activity of recombinant tumor necrosis factor on mouse fibrosarcoma in vivo and in vitro.
Tomazic VJ; Farha M; Loftus A; Elias EG
J Immunol; 1988 Jun; 140(11):4056-61. PubMed ID: 3372997
[TBL] [Abstract][Full Text] [Related]
8. Acute effects of human recombinant tumor necrosis factor-alpha on the cerebral vasculature of the rat in both normal brain and in an experimental glioma model.
Kido G; Wright JL; Merchant RE
J Neurooncol; 1991 Apr; 10(2):95-109. PubMed ID: 1716671
[TBL] [Abstract][Full Text] [Related]
9. Synergistic action of human recombinant tumor necrosis factor with endotoxins or nontoxic poly A:U against solid Meth A tumors in mice.
Bloksma N; Hofhuis FM
Cancer Immunol Immunother; 1987; 24(2):165-71. PubMed ID: 3829051
[TBL] [Abstract][Full Text] [Related]
10. Role of tissue factor in the antitumor effect of recombinant human tumor necrosis factor-alpha in mice.
Nishigaki F; Miyayasu K; Tsujimoto S; Manda T; Shimomura K
Anticancer Res; 1994; 14(6B):2573-6. PubMed ID: 7872683
[TBL] [Abstract][Full Text] [Related]
11. Biological activities of novel recombinant tumor necrosis factor having N-terminal amino acid sequences derived from cytotoxic factors produced by THP-1 cells.
Soma G; Tsuji Y; Tanabe Y; Noguchi K; Kitahara-Tanabe N; Gatanaga T; Inagawa H; Kawakami M; Mizuno D
J Biol Response Mod; 1988 Dec; 7(6):587-95. PubMed ID: 2851034
[TBL] [Abstract][Full Text] [Related]
12. In vivo effects of human recombinant tumor necrosis factor alone and in combination with other biological response modifiers on human digestive organ cancer xenografts transplanted in nude mice.
Nio Y; Shiraishi T; Tsubono M; Morimoto H; Tseng CC; Kawabata K; Masai Y; Tun T; Fukumoto M; Tobe T
Biotherapy; 1991; 3(4):337-44. PubMed ID: 1786197
[TBL] [Abstract][Full Text] [Related]
13. Antitumor activity of murine tumor necrosis factor (TNF) against transplanted murine tumors and heterotransplanted human tumors in nude mice.
Haranaka K; Satomi N; Sakurai A
Int J Cancer; 1984 Aug; 34(2):263-7. PubMed ID: 6469400
[TBL] [Abstract][Full Text] [Related]
14. Potentiation of therapeutic effect of recombinant tumor necrosis factor against B16 mouse melanoma by combination with recombinant interleukin 2.
Urano K; Habu S; Nishimura T
Cytokine; 1993 May; 5(3):224-9. PubMed ID: 8218934
[TBL] [Abstract][Full Text] [Related]
15. Anti-tumor effect of lipopolysaccharide by intradermal administration as a novel drug delivery system.
Inagawa H; Nishizawa T; Noguchi K; Minamimura M; Takagi K; Goto S; Soma G; Mizuno D
Anticancer Res; 1997; 17(3C):2153-8. PubMed ID: 9216680
[TBL] [Abstract][Full Text] [Related]
16. Potentiation of the toxicity of tumor necrosis factor by tumors in mice.
Nishigaki F; Miyayasu K; Tsujimoto S; Manda T; Shimomura K
Circ Shock; 1994 Oct; 44(2):77-83. PubMed ID: 7743604
[TBL] [Abstract][Full Text] [Related]
17. Recombinant human tumor necrosis factor--II. Antitumor effect on murine and human tumors transplanted in mice.
Sohmura Y; Nakata K; Yoshida H; Kashimoto S; Matsui Y; Furuichi H
Int J Immunopharmacol; 1986; 8(3):357-68. PubMed ID: 3525434
[TBL] [Abstract][Full Text] [Related]
18. Lack of antitumour activity of human recombinant tumour necrosis factor-alpha, alone or in combination with melphalan in a nude mouse human melanoma xenograft system.
Furrer M; Altermatt HJ; Ris HB; Althaus U; Rüegg C; Liénard D; Lejeune FJ
Melanoma Res; 1997 Aug; 7 Suppl 2():S43-9. PubMed ID: 9578416
[TBL] [Abstract][Full Text] [Related]
19. Recombinant human tumor necrosis factor-alpha: thrombus formation is a cause of anti-tumor activity.
Shimomura K; Manda T; Mukumoto S; Kobayashi K; Nakano K; Mori J
Int J Cancer; 1988 Feb; 41(2):243-7. PubMed ID: 3338873
[TBL] [Abstract][Full Text] [Related]
20. Immunochemotherapy for murine bladder tumor with a new human recombinant tumor necrosis factor (rTNF-S), VP-16 and hyperthermia.
Iizumi T; Yazaki T; Waku M; Soma G
J Urol; 1989 Aug; 142(2 Pt 1):386-9. PubMed ID: 2746758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
